2nd Oncology Strategy Meeting Europe 2016

Senior biopharma leaders gather to explore key strategic challenges in oncology through roundtable and 1:1 discussions.

Heathrow/Windsor Marriott, London, UK

March 08, 2016  -  March 09, 2016

Register Save to Calendar


Quintiles and Q² Solutions join senior biopharma leaders involved in oncology drug development to discuss current challenges and topical issues through a series of interactive roundtables, panel discussions and 1:1 meetings.

Scott Davis, Sr. Director, Therapeutic Science and Strategy, Quintiles will facilitate the following roundtable session:

Operational strategies for executing complex multi-arm PhIB/II studies

  • Flexibility and adaptability: Enrollment planning and modelling
  • Agility and proactivity in planning for database changes and study additions
  • Medical monitoring and new safety signals of combination therapies

Paul Berry, Global Senior Director, Scientific Support, Q² Solutions will facilitate the following roundtable session: 

Ensure correct patient selection assays are utilized in the clinical trial

  • Addressing challenges to improve quality management in anatomic pathology
  • Future of digital pathology for validation and standardization of patient selection
  • Adoption and utilization of biomarkers for patient pre-profiling and efficacy